Evidence map›Paper›PMID 41325422›Full record

ArticlePLoS pathogens2025

Paramyxovirus matrix protein redirects METTL3 for dual regulation of viral replication and immune evasion.

Takashi Okura, Yusuke Nakai, Taichi Kameya, Fuminori Mizukoshi, Hiyori Okura, Masatoshi Kakizaki, Fumihiro Kato, Yusuke Matsumoto, Yuichiro Nakatsu, Kaoru Takeuchi and 6 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Takashi OkuraDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Yusuke NakaiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Taichi KameyaDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Fuminori MizukoshiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Hiyori OkuraDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Masatoshi KakizakiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Fumihiro KatoDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Yusuke MatsumotoTransboundary Animal Diseases Research Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Yuichiro NakatsuDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Kaoru TakeuchiTokiwa-Bio Inc., Tsukuba, Ibaraki, Japan.
Hirokazu KimuraDepartment of Health Science, Graduate School of Health Sciences, Gunma Paz University, Takasaki, Gunma, Japan.
Makoto TakedaDepartment of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Noriyuki OtsukiDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Kazuya ShiratoDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.
Hideki HasegawaResearch Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.
Akihide RyoDepartment of Virology 3, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-6019-958X

Funding

Japan Agency for Medical Research and Development (AMED)Japan Society for the Promotion of Science KAKENHIStrategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA)
6 · The paper itself

Abstract

N6-methyladenosine (m6A) epitranscriptomic modifications play crucial roles in regulating both host and viral gene expression. Here, we revealed a novel mechanism by which paramyxoviruses exploit host m6A machinery to simultaneously enhance viral replication and suppress host immunity. Our results demonstrated that the viral matrix protein (M) of bovine parainfluenza virus type 3 (BPIV3) binds to the methyltransferase domain of METTL3 in the nucleus and facilitates its translocation to the cytoplasm through an exportin-1-dependent pathway. This mechanism is conserved across multiple paramyxoviruses, including human parainfluenza virus type 3, Sendai virus, Nipah virus, and measles virus, suggesting an evolutionarily conserved viral strategy. The relocated METTL3 catalyzes m6A modification at specific sites within viral nucleocapsid protein (N) mRNA, significantly enhancing its stability and protein expression. Using reverse genetics, we generated recombinant viruses harbouring mutations at these m6A acceptor sites, which exhibited markedly attenuated viral replication, confirming the critical role of these epitranscriptomic marks in the viral life cycle. Rescue experiments demonstrated that the expression of exogenous N protein partially restored the viral titer and concomitant genome/antigenome synthesis in m6A site mutant, indicating that reduced N protein abundance represents a key mechanism underlying impaired viral replication. Furthermore, M protein-mediated depletion of nuclear METTL3 significantly reduces m6A modification of host IFN-β mRNA, resulting in diminished interferon expression and compromised antiviral responses. Supporting this mechanism, infection with viruses bearing nuclear export signal mutations that prevent METTL3 cytoplasmic translocation, maintained IFN-β mRNA m6A modification and resulted in significantly elevated IFN-β expression. These findings provide direct mechanistic evidence that paramyxoviruses utilize M-driven METTL3 relocalization as a sophisticated immune evasion strategy. Our study illuminates how paramyxoviruses strategically manipulate epitranscriptomic regulation to create an environment conducive to viral propagation, thereby advancing our understanding of virus-host interactions and identifying potential targets for antiviral therapeutics.

Indexed as

Immune EvasionMethyltransferasesParamyxovirinaeViral Matrix ProteinsVirus ReplicationAdenosineAnimalsHost-Pathogen InteractionsHumansAdenosineMethyltransferasesMETTL3 protein, humanN-methyladenosineViral Matrix Proteins

Identifiers

PMID41325422
PMCPMC12680350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.